Neurology - Medicine.net

Researchers use AI-powered method to identify genetic epilepsies earlier than current genetic diagnosis

byChildren's Hospital of PhiladelphiaCredit: CC0 Public DomainDiagnosing the genetic cause of a disease can aid in finding therapies and directing treatment, but often these diagnoses occur

Updated on: August 08,2024

Researchers use AI-powered method to identify genetic epilepsies earlier than current genetic diagnosis

byChildren's Hospital of PhiladelphiaCredit: CC0 Public DomainDiagnosing the genetic cause of a disease can aid in finding therapies and directing treatment, but often these diagnoses occur

Updated on:August 08,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on: March 07,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on:March 07,2024

Alzheimer's disease destroys neurons that keep us awake

by University of California, San FranciscoCredit: CC0 Public DomainResearchers and caregivers have noted that excessive daytime napping can develop long before the memory problems associated with

Updated on: April 10,2024

Alzheimer's disease destroys neurons that keep us awake

by University of California, San FranciscoCredit: CC0 Public DomainResearchers and caregivers have noted that excessive daytime napping can develop long before the memory problems associated with

Updated on:April 10,2024

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on: March 30,2024

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on:March 30,2024

Women with ovarian removal have unique risk and resilience factors for Alzheimer disease, research finds

byUniversity of TorontoCredit: Pixabay/CC0 Public DomainResearch published by a team of researchers from the University of Toronto in collaboration with colleagues from the University of Alberta

Updated on: December 11,2024

Women with ovarian removal have unique risk and resilience factors for Alzheimer disease, research finds

byUniversity of TorontoCredit: Pixabay/CC0 Public DomainResearch published by a team of researchers from the University of Toronto in collaboration with colleagues from the University of Alberta

Updated on:December 11,2024

Detecting consciousness with EEGs, soundscapes and clowns

by Béatrice St-Cyr-Leroux,University of MontrealWorkshop 3 in the sound design process of Resonance, where a therapeutic clown duo (Dr. Fifi and Dr. Tcheksa) interacted with the real-time sonifi

Updated on: November 28,2024

Detecting consciousness with EEGs, soundscapes and clowns

by Béatrice St-Cyr-Leroux,University of MontrealWorkshop 3 in the sound design process of Resonance, where a therapeutic clown duo (Dr. Fifi and Dr. Tcheksa) interacted with the real-time sonifi

Updated on:November 28,2024

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on: March 07,2024

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on:March 07,2024

Researchers identify new mutation in gene linked to amyotrophic lateral sclerosis

by Institut de Recerca Sant Pau (Sant Pau Research Institute)(A) Map of Spain and its regions. (B) Map of La Rioja province and its regions. Regions belonging to the south-eastern area of La Rioja, wh

Updated on: July 17,2024

Researchers identify new mutation in gene linked to amyotrophic lateral sclerosis

by Institut de Recerca Sant Pau (Sant Pau Research Institute)(A) Map of Spain and its regions. (B) Map of La Rioja province and its regions. Regions belonging to the south-eastern area of La Rioja, wh

Updated on:July 17,2024

No clinical symptoms in study of Alzheimer's transmissibility

by Medical University of ViennaMedUni Vienna researchers have published the results of a clarifying research study on the potential transmissibility of Alzheimer's disease. Although the prote

Updated on: February 28,2024

No clinical symptoms in study of Alzheimer's transmissibility

by Medical University of ViennaMedUni Vienna researchers have published the results of a clarifying research study on the potential transmissibility of Alzheimer's disease. Although the prote

Updated on:February 28,2024

A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

by University of HelsinkiCredit: Pixabay/CC0 Public DomainA study conducted at the University of Helsinki and the Helsinki University Hospital (HUS) suggests that the APOE4 allele may also increa

Updated on: April 08,2024

A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

by University of HelsinkiCredit: Pixabay/CC0 Public DomainA study conducted at the University of Helsinki and the Helsinki University Hospital (HUS) suggests that the APOE4 allele may also increa

Updated on:April 08,2024

Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

by University of GlasgowCredit: Pixabay/CC0 Public DomainHealthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores